Boston Scientific Touts Data On "Purpose-Built" Drug-Eluting Peripheral Stent
This article was originally published in The Gray Sheet
Executive Summary
The firm's Eluvia paclitaxel eluting stent, design for peripheral arteries, showed positive results in data from a small trial presented April 28 at the Charing Cross International Symposium in London.